Pharmafile Logo
Pharmafocus logo
Advanced Search

Glaucoma

Showing 4 posts of 4 posts found.

bham_uni

Birmingham research paves way for new anti-fibrotic glaucoma treatment

January 8, 2021
Medical Communications Glaucoma, University of Birmingham

New research from the University of Birmingham has shown that a novel low molecular weight dextran-sulphate, ILB, could play a …

News
fda2outsideweb

Aerie’s glaucoma drug gets strong preliminary FDA opinion

October 12, 2017
Sales and Marketing Aerie, Aerie Pharmaceutical, FDA, Glaucoma, Rhopressa, pharma

In a preliminary review of the drug, the FDA has judged that Aerie Pharmaceutical’s experimental glaucoma treatment Rhopressa (netarsudil) effectively …

News
inotek_logo

Inotek’s glaucoma lead candidate falls at Phase 3 trial

January 4, 2017
Research and Development Glaucoma, inotek, inotek pharma

Inotek Pharmaceutical announced that its lead candidate, trabodenoson, a drug designed to treat glaucoma, had failed to outperform placebos in …

News
needles

Valeant receives complete response letter from FDA on glaucoma drug

July 22, 2016
Medical Communications, Sales and Marketing FDA, Glaucoma, Valeant

Valeant Pharmaceuticals has announced that it has received a complete response letter from the FDA rejecting their new drug application …

News

Latest content

Ardena announces €20m expansion following first GMP approval

April 19, 2024

Roche’s Alecensa approved by FDA as lung cancer treatment

April 19, 2024

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024